These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10217625)

  • 1. Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein.
    Hada T; Kondo M; Yasukawa K; Amuro Y; Higashino K
    Clin Chim Acta; 1999 Mar; 281(1-2):37-46. PubMed ID: 10217625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay (ELISA) for Aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis.
    Kondo M; Hada T; Fukui K; Iwasaki A; Higashino K; Yasukawa K
    Clin Chim Acta; 1995 Dec; 243(1):1-9. PubMed ID: 8747509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
    Ohkura T; Hada T; Higashino K; Ohue T; Kochibe N; Koide N; Yamashita K
    Cancer Res; 1994 Jan; 54(1):55-61. PubMed ID: 8261462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of liver cirrhosis from chronic hepatitis by analysis of serum cholinesterase isozymes using affinity electrophoresis with concanavalin A or wheat germ agglutinin.
    Hada T; Ohue T; Imanishi H; Nakaoka H; Hirosaki A; Shimomura S; Fujikura M; Matsuda Y; Yamamoto T; Amuro Y
    Gastroenterol Jpn; 1990 Dec; 25(6):715-9. PubMed ID: 2279633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases.
    Li L; Gu X; Fang M; Ji J; Yi C; Gao C
    Clin Chem Lab Med; 2016 Apr; 54(4):693-701. PubMed ID: 26035113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
    Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
    Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
    Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum cholinesterase activity (CHE) in different classes of chronic liver diseases (author's transl)].
    Galanti B; Russo M; Nardiello S; Guarino F
    Quad Sclavo Diagn; 1978 Mar; 14(1):95-102. PubMed ID: 746115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.
    Kudo M; Zheng RQ; Kim SR; Okabe Y; Osaki Y; Iijima H; Itani T; Kasugai H; Kanematsu M; Ito K; Usuki N; Shimamatsu K; Kage M; Kojiro M
    Intervirology; 2008; 51 Suppl 1():17-26. PubMed ID: 18544944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum hyaluronan in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Nishimura Y; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):459-65. PubMed ID: 8743918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cholinesterase is an excellent biomarker of liver cirrhosis.
    Ramachandran J; Sajith KG; Priya S; Dutta AK; Balasubramanian KA
    Trop Gastroenterol; 2014; 35(1):15-20. PubMed ID: 25276901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.
    Spadaro A; Ajello A; Morace C; Zirilli A; D'arrigo G; Luigiano C; Martino F; Bene A; Migliorato D; Turiano S; Ferraù O; Freni MA
    World J Gastroenterol; 2005 Apr; 11(13):1987-90. PubMed ID: 15800991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
    Shang S; Qin X; Li W; Zhang S; Liu Y
    Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis.
    Jin BX; Zhang YH; Jin WJ; Sun XY; Qiao GF; Wei YY; Sun LB; Zhang WH; Li N
    Sci Rep; 2015 Oct; 5():15026. PubMed ID: 26456479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
    Shu H; Li W; Shang S; Qin X; Zhang S; Liu Y
    Discov Med; 2017 Mar; 23(126):163-168. PubMed ID: 28472609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
    Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
    PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Place of serum cholinesterase in the diagnosis of chronic liver diseases].
    Dimov DM; Iordanova IU; Donchev P
    Vutr Boles; 1975; 14(4):40-6. PubMed ID: 1224594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Vascular Endothelial Growth Factor Receptor-2 as a Predictive Factor for Progression of Illness in Chronic Liver Diseases and Hepatocellular Carcinoma.
    Ratnasari N; Nurdjanah S; Sadewa AH; Hakimi M; Yano Y
    Kobe J Med Sci; 2015 Dec; 61(3):E89-96. PubMed ID: 27323788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.